EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Levels of Lysozyme and SLPI in Bronchoalveolar Lavage: Exploring Their Role in Interstitial Lung Disease

Rubén Osuna-Gómez iD, Maria Mulet iD, Silvia Barril, Elisabet Cantó, Paloma Millan-Billi, Ana Pardessus, David de la Rosa-Carrillo iD, Diego Castillo iD, Silvia Vidal iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25084297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Rubén Osuna-Gómez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Inflammatory Diseases, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain. Hauptthemen laut MEDLINE: Muramidase, Secretory Leukocyte Peptidase Inhibitor, Bronchoalveolar Lavage Fluid, Lung Diseases, Interstitial. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interstitial lung diseases (ILDs) are characterized by inflammation or fibrosis of the pulmonary parenchyma. Despite the involvement of immune cells and soluble mediators in pulmonary fibrosis, the influence of antimicrobial peptides (AMPs) remains underexplored. These effector molecules display a range of activities, which include immunomodulation and wound repair. Here, we investigate the role of AMPs in the development of fibrosis in ILD. We compare the concentration of different AMPs and different cytokines in 46 fibrotic (F-ILD) and 17 non-fibrotic (NF-ILD) patients by ELISA and using peripheral blood mononuclear cells from in vitro stimulation in the presence of lysozyme or secretory leukocyte protease inhibitor (SLPI) from 10 healthy donors. We observed that bronchoalveolar lavage (BAL) levels of AMPs were decreased in F-ILD patients (lysozyme: p < 0.001; SLPI: p < 0.001; LL-37: p < 0.001; lactoferrin: p = 0.47) and were negatively correlated with levels of TGF-β (lysozyme: p = 0.02; SLPI: p < 0.001) and IL-17 (lysozyme: p < 0.001; SLPI: p < 0.001). We observed that lysozyme increased the percentage of CD86+ macrophages (p < 0.001) and the production of TNF-α (p < 0.001). We showed that lysozyme and SLPI were associated with clinical parameters (lysozyme: p < 0.001; SLPI: p < 0.001) and disease progression (lysozyme: p < 0.001; SLPI: p = 0.01). These results suggest that AMPs may play an important role in the anti-fibrotic response, regulating the effect of pro-fibrotic cytokines. In addition, levels of lysozyme in BAL may be a potential biomarker to predict the progression in F-ILD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MuramidaseSecretory Leukocyte Peptidase InhibitorBronchoalveolar Lavage FluidLung Diseases, InterstitialHumansMaleFemaleMiddle AgedAgedCytokinesAdultBiomarkersBronchoalveolar LavageLeukocytes, Mononuclear

Stichwörter der Autor:innen

AMPsSLPIfibrosisimmune cellslysozyme

Substanzen

MuramidaseSecretory Leukocyte Peptidase InhibitorSLPI protein, humanCytokinesBiomarkers

Autor:innen und Institutionen

  • Inflammatory Diseases, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.
  • Respiratory Department, Institut de Recerca Biomèdica de Lleida (IRBLleida), Hospital Universitari Arnau de Vilanova-Santa María, Translational Research in Respiratory Medicine, Universitat de Lleida (UdL), 25198 Lleida…
  • Department of Respiratory, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
  • Department of Respiratory, Hospital Universitario Germans Trias i Pujol, 08916 Barcelona, Spain.

ORCID-Profile: Rubén Osuna-Gómez, Maria Mulet, David de la Rosa-Carrillo, Diego Castillo, Silvia Vidal

Zitieren

APA

Osuna-Gómez, R., Mulet, M., Barril, S., Cantó, E., Millan-Billi, P., Pardessus, A., de la Rosa-Carrillo, D., Castillo, D., & Vidal, S. (2024). Levels of Lysozyme and SLPI in Bronchoalveolar Lavage: Exploring Their Role in Interstitial Lung Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084297

Vancouver

Osuna-Gómez R, Mulet M, Barril S, Cantó E, Millan-Billi P, Pardessus A, et al. Levels of Lysozyme and SLPI in Bronchoalveolar Lavage: Exploring Their Role in Interstitial Lung Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084297

BibTeX
@article{OsunaGmez2024,
  author = {Osuna-Gómez, Rubén and Mulet, Maria and Barril, Silvia and Cantó, Elisabet and Millan-Billi, Paloma and Pardessus, Ana and de la Rosa-Carrillo, David and Castillo, Diego and Vidal, Silvia},
  title = {Levels of Lysozyme and SLPI in Bronchoalveolar Lavage: Exploring Their Role in Interstitial Lung Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25084297}
}
Kostenlos starten →